FDA Inspection 1267275 — Nitin Kulkarni, MBBS
The FDA completed an inspection of Nitin Kulkarni, MBBS on March 21, 2025 in Pune. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 21, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Pune (India)
Additional Details
Clinical BA/BE